Table 3 Frequency of new patients with uveitis (2013–2015) by age
< 20 years (n = 31) | No. of patients (%) | 20–59 years (n = 358) | No. of patients (%) | ≥60 years (n = 409) | No. of patients (%) |
|---|---|---|---|---|---|
Juvenile chronic iridocyclitis | 11 (35.5) | Behçet’s disease | 24 (7.1) | Herpetic iridocyclitis | 37 (9.7) |
Fuchs heterochronic iridocyclitis | 3 (9.7) | Herpetic iridocyclitis | 19 (5.7) | Sarcoidosis | 27 (7.0) |
Bechet disease | 3 (9.7) | Sarcoidosis | 19 (5.7) | Intraocular lymphoma | 27 (7.0) |
Posner-Schlossman syndrome | 2 (6.5) | Vogt-Koyanagi-Harada disease | 16 (4.8) | Bacterial endophthalmitis | 20 (5.2) |
HTLV-1-associated uveitis | 1 (3.2) | Posner-Schlossman syndrome | 13 (3.9) | Vogt-Koyanagi-Harada disease | 14 (3.7) |
JIA | 1 (3.2) | Acute anterior uveitis | 12 (3.6) | Fungal endophthalmitis | 12 (3.1) |
Cat scratch disease | 1 (3.2) | Fuchs heterochromic iridocyclitis | 10 (3.0) | HTLV-1-associated uveitis | 11 (2.9) |
Cytomegalovirus retinitis | 1 (3.2) | MEWDS | 8 (2.4) | Posner-Schlossman syndrome | 10 (2.6) |
Vogt-Koyanagi-Harada disease | 1 (3.2) | AZOOR | 7 (2.1) | Cytomegalovirus retinitis | 8 (2.1) |
Toxoplasma | 1 (3.2) | Juvenile chronic iridocyclitis | 6 (1.8) | Fuchs heterochromic iridocyclitis | 7 (1.8) |
Unknown | 6 (19.4) | Acute retinal necrosis | 6 (1.8) | Acute retinal necrosis | 7 (1.8) |
Tuberculosis | 6 (1.8) | Lens induced uveitis | 6 (1.6) | ||
IBD | 5 (1.5) | Behçet’s disease | 6 (1.6) | ||
Systemic lupus erythematosus | 4 (1.2) | Diabetic iridocyclitis | 4 (1.0) | ||
Psoriatic uveitis | 4 (1.2) | Psoriatic uveitis | 3 (0.8) | ||
Intraocular lymphoma | 4 (1.2) | Tuberculosis | 3 (0.8) | ||
Neuroretinitis | 4 (1.2) | Syphilis | 3 (0.8) | ||
Fungal endophthalmitis | 4 (1.2) | APMPPE | 3 (0.8) | ||
Toxoplasma | 3 (0.9) | Toxoplasma | 2 (0.5) | ||
Bacterial endophthalmitis | 3 (0.9) | Acute anterior uveitis | 2 (0.5) | ||
Rubella virus-associated uveitis | 3 (0.9) | Sympathetic ophthalmia | 2 (0.5) | ||
Multiple sclerosis | 2 (0.6) | Neuroretinitis | 2 (0.5) | ||
Ankylosing spondylitis | 2 (0.6) | AZOOR | 1 (0.3) | ||
Multifocal choroiditis and panuveitis | 2 (0.6) | CAR | 1 (0.3) | ||
APMPPE | 1 (0.3) | Immune reconstitution syndrome | 1 (0.3) | ||
Cytomegalovirus retinitis | 1 (0.3) | Polymyalgia rheumatica | 1 (0.3) | ||
Immune reconstitution syndrome | 1 (0.3) | RA | 1 (0.3) | ||
HTLV-1-associated uveitis | 1 (0.3) | Sclerouveitis due to scleroderma | 1 (0.3) | ||
JIA | 1 (0.3) | Geographic chorioretinopathy | 1 (0.3) | ||
PIC | 1 (0.3) | Unknown | 160 (41.8) | ||
RA | 1 (0.3) | ||||
UAIM | 1 (0.3) | ||||
Iridocyclitis due to nivolumab | 1 (0.3) | ||||
Sclerouveitis due to scleroderma | 1 (0.3) | ||||
Geographic chorioretinopathy | 1 (0.3) | ||||
Unknown | 139 (41.4) | ||||
Total | 31 | Total | 336 | Total | 383 |